Variant report
| Variant | esv11760 |
|---|---|
| Chromosome Location | chr7:102614464-102617348 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:246)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
|---|---|---|---|---|---|---|
| 1 | ARID3A | chr7:102615512-102615697 | K562 | blood: | n/a | n/a |
| 2 | ATF1 | chr7:102615471-102615652 | K562 | blood: | n/a | n/a |
| 3 | BHLHE40 | chr7:102615498-102615614 | K562 | blood: | n/a | n/a |
| 4 | CBX3 | chr7:102613423-102614555 | K562 | blood: | n/a | n/a |
| 5 | CBX3 | chr7:102616799-102617613 | K562 | blood: | n/a | n/a |
| 6 | CBX3 | chr7:102615174-102615822 | K562 | blood: | n/a | n/a |
| 7 | CBX3 | chr7:102616016-102616744 | K562 | blood: | n/a | n/a |
| 8 | CHD2 | chr7:102616910-102617141 | K562 | blood: | n/a | n/a |
| 9 | CHD2 | chr7:102615129-102615353 | K562 | blood: | n/a | n/a |
| 10 | CTCF | chr7:102615512-102615674 | GM19238 | blood: | n/a | n/a |
| 11 | CTCF | chr7:102615460-102615610 | HCT-116 | colon: | n/a | n/a |
| 12 | CTCF | chr7:102615540-102615653 | NHEK | skin: | n/a | n/a |
| 13 | CTCF | chr7:102615520-102615670 | RPTEC | kidney: | n/a | n/a |
| 14 | CTCF | chr7:102615500-102615650 | HCFaa | heart: | n/a | n/a |
| 15 | CTCF | chr7:102615424-102615784 | A549 | lung: | n/a | n/a |
| 16 | CTCF | chr7:102615500-102615650 | GM12867 | blood: | n/a | n/a |
| 17 | CTCF | chr7:102615540-102615690 | NHEK | skin: | n/a | n/a |
| 18 | CTCF | chr7:102615540-102615690 | AG10803 | skin: | n/a | n/a |
| 19 | CTCF | chr7:102615560-102615710 | GM12865 | blood: | n/a | n/a |
| 20 | CTCF | chr7:102615560-102615710 | GM12868 | blood: | n/a | n/a |
| 21 | CTCF | chr7:102615560-102615710 | HFF-Myc | foreskin: | n/a | n/a |
| 22 | CTCF | chr7:102615480-102615630 | MCF-7 | breast: | n/a | n/a |
| 23 | CTCF | chr7:102615540-102615690 | HCPEpiC | choroid plexus: | n/a | n/a |
| 24 | CTCF | chr7:102615316-102615844 | K562 | blood: | n/a | n/a |
| 25 | CTCF | chr7:102615549-102615638 | Kidney_OC | kidney: | n/a | n/a |
| 26 | CTCF | chr7:102615520-102615670 | BJ | skin: | n/a | n/a |
| 27 | CTCF | chr7:102615500-102615650 | GM12872 | blood: | n/a | n/a |
| 28 | CTCF | chr7:102615557-102615688 | HUVEC | blood vessel: | n/a | n/a |
| 29 | CTCF | chr7:102615560-102615710 | GM12873 | blood: | n/a | n/a |
| 30 | CTCF | chr7:102615537-102615703 | Hela-S3 | cervix: | n/a | n/a |
| 31 | CTCF | chr7:102615480-102615630 | Caco-2 | colon: | n/a | n/a |
| 32 | CTCF | chr7:102615500-102615650 | HPF | lung: | n/a | n/a |
| 33 | CTCF | chr7:102615412-102615718 | K562 | blood: | n/a | n/a |
| 34 | CTCF | chr7:102615520-102615670 | K562 | blood: | n/a | n/a |
| 35 | CTCF | chr7:102615421-102615701 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 36 | CTCF | chr7:102615540-102615690 | GM12870 | blood: | n/a | n/a |
| 37 | CTCF | chr7:102615520-102615670 | AG09309 | skin: | n/a | n/a |
| 38 | CTCF | chr7:102615480-102615630 | GM12878 | blood: | n/a | n/a |
| 39 | CTCF | chr7:102615540-102615690 | WERI-Rb-1 | eye: | n/a | n/a |
| 40 | CTCF | chr7:102615500-102615650 | GM12871 | blood: | n/a | n/a |
| 41 | CTCF | chr7:102615520-102615670 | GM12872 | blood: | n/a | n/a |
| 42 | CTCF | chr7:102615560-102615710 | HCM | heart: | n/a | n/a |
| 43 | CTCF | chr7:102615369-102615702 | HCT-116 | colon: | n/a | n/a |
| 44 | CTCF | chr7:102615503-102615672 | HepG2 | liver: | n/a | n/a |
| 45 | CTCF | chr7:102615507-102615696 | GM12878 | blood: | n/a | n/a |
| 46 | CTCF | chr7:102615516-102615697 | Gliobla | brain: | n/a | n/a |
| 47 | CTCF | chr7:102615560-102615710 | NB4 | blood: | n/a | n/a |
| 48 | CTCF | chr7:102615558-102615690 | Medullo | brain: | n/a | n/a |
| 49 | CTCF | chr7:102615500-102615650 | BE2_C | brain: | n/a | n/a |
| 50 | CTCF | chr7:102615560-102615710 | A549 | lung: | n/a | n/a |
| No data |
(count:6 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr7:102616376..102618625-chr7:102696676..102699468,2 | K562 | blood: | |
| 2 | chr7:102451931..102453738-chr7:102614138..102615717,2 | K562 | blood: | |
| 3 | chr7:102613006..102614516-chr7:102715583..102717366,2 | K562 | blood: | |
| 4 | chr7:102616176..102618073-chr7:103034545..103036072,2 | K562 | blood: | |
| 5 | chr7:102452440..102454909-chr7:102615064..102617723,2 | K562 | blood: | |
| 6 | chr7:102497060..102498758-chr7:102613043..102615053,2 | K562 | blood: |
| No data |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| FBXL13 | TF binding region |
| ENSG00000238324 | chromatin interactions |
| ENSG00000170632 | chromatin interactions |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs545727852 | chr7:102614469-102614470 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
| 2 | rs530329439 | chr7:102614470-102614471 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
| 3 | rs183225738 | chr7:102614547-102614548 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 4 | rs188478756 | chr7:102614554-102614555 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 5 | rs527240770 | chr7:102614557-102614558 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 6 | rs543174583 | chr7:102614566-102614567 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 7 | rs193128365 | chr7:102614595-102614596 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 8 | rs531415412 | chr7:102614601-102614602 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 9 | rs113646566 | chr7:102614610-102614611 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 10 | rs184839610 | chr7:102614613-102614614 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 11 | rs146817362 | chr7:102614628-102614629 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 12 | rs189353490 | chr7:102614631-102614632 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 13 | rs547293120 | chr7:102614647-102614648 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 14 | rs13245825 | chr7:102614698-102614699 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 15 | rs529861845 | chr7:102614764-102614765 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 16 | rs192305527 | chr7:102614897-102614898 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 17 | rs546672778 | chr7:102614981-102614982 | Weak transcription Flanking Active TSS Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 18 | rs374057142 | chr7:102615011-102615012 | Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 19 | rs538135032 | chr7:102615023-102615024 | Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 20 | rs567681052 | chr7:102615026-102615027 | Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 21 | rs73408279 | chr7:102615042-102615043 | Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
| 22 | rs556451648 | chr7:102615056-102615057 | Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 23 | rs147582951 | chr7:102615195-102615196 | Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 24 | rs142102579 | chr7:102615221-102615222 | Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 25 | rs568147989 | chr7:102615251-102615252 | Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 26 | rs75924751 | chr7:102615416-102615417 | Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 27 | rs535660063 | chr7:102615431-102615432 | Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 28 | rs554524134 | chr7:102615484-102615485 | Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 29 | rs145759181 | chr7:102615542-102615543 | Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 30 | rs542879956 | chr7:102615554-102615555 | Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 31 | rs370079295 | chr7:102615612-102615613 | Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 32 | rs576097900 | chr7:102615683-102615684 | Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 33 | rs138355526 | chr7:102615707-102615708 | Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 34 | rs10225811 | chr7:102615714-102615715 | Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 35 | rs143585398 | chr7:102615810-102615811 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 36 | rs540589429 | chr7:102615890-102615891 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 37 | rs559419464 | chr7:102615909-102615910 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 38 | rs183692195 | chr7:102615915-102615916 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 39 | rs148066003 | chr7:102616036-102616037 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 40 | rs548130548 | chr7:102616051-102616052 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 41 | rs529762995 | chr7:102616080-102616081 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 42 | rs189318098 | chr7:102616116-102616117 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 43 | rs181387187 | chr7:102616142-102616143 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 44 | rs186538396 | chr7:102616147-102616148 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 45 | rs73714540 | chr7:102616217-102616218 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 46 | rs539072261 | chr7:102616238-102616239 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 47 | rs547748951 | chr7:102616277-102616278 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 48 | rs558521613 | chr7:102616303-102616304 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 49 | rs369247046 | chr7:102616325-102616326 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 50 | rs190154497 | chr7:102616332-102616333 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Basal cell lymphoma | 17170743 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Seminomas | 18059402 | CNVD |
| Testicular cancer | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Autism | 19415332 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Malaria | 21533027 | CNVD |
| Melanoma | 18172304 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| head and neck squamous cell carcinoma | 19289630 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Ewing''s sarcoma | 17952124 | CNVD |
| Autism | 22495311 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Gastric cancer | 24379144 | CNVD |
| Glioblastoma multiforme | 17002787 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Lissencephaly | 21572526 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Squamous cell cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Low-grade fibromyxoid sarcoma | 0 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Burkitt''s lymphoma | 18698080 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Shwachman-Diamond syndrome | 22934832 | CNVD |
| Colorectal cancer | 19359472 | CNVD |
| Cutaneous malignant melanoma | 17690212 | CNVD |
| Leukemia | 17361228 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Peripheral t-cell lymphoma | 19118030 | CNVD |
| Malignant melanoma | 17690212 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Neurodevelopmental disorder | 22521361 | CNVD |
| abortions and stillbirths | 19751515 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Prostate cancer | 16461572 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Burkitt''s lymphoma | 19759907 | CNVD |
| Malignant melanoma | 17260012 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Bladder cancer | 21909424 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Splenic marginal zone lymphoma | 21957467 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Primary central nervous system lymphoma | 21088137 | CNVD |
| Liver carcinoma | 19366792 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Adenocarcinoma | 19607727 | CNVD |
| Multiple myeloma | 16461302 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Emphysema | 19352772 | CNVD |
| Effusion lymphoma | 18079361 | CNVD |
| Medulloblastoma | 17653508 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Autism | 19401682 | CNVD |
| Neuroticism | 17667963 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Cancer | 19907438 | CNVD |
| Breast cancer | 21364760 | CNVD |
| abnormal development | 18461090 | CNVD |
| Pancreatic cancer | 17952125 | CNVD |
| Breast cancer | 22522925 | CNVD |
| Cancer | 20164919 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr7:102591000-102619400 | Weak transcription | HSMM | muscle |
| 2 | chr7:102608800-102618600 | Weak transcription | Osteobl | bone |
| 3 | chr7:102611800-102615000 | Active TSS | K562 | blood |
| 4 | chr7:102613000-102625600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
| 5 | chr7:102613200-102631200 | Weak transcription | Primary hematopoietic stem cells | blood |
| 6 | chr7:102613600-102615800 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
| 7 | chr7:102613800-102615600 | Enhancers | HUVEC | blood vessel |
| 8 | chr7:102613800-102617000 | Weak transcription | Fetal Stomach | stomach |
| 9 | chr7:102613800-102618600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
| 10 | chr7:102614200-102615200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
| 11 | chr7:102614200-102618600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
| 12 | chr7:102614200-102618800 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
| 13 | chr7:102614400-102615200 | Weak transcription | H1 Cell Line | embryonic stem cell |
| 14 | chr7:102615000-102618000 | Transcr. at gene 5' and 3' | K562 | blood |
| 15 | chr7:102615200-102615400 | Enhancers | H1 Cell Line | embryonic stem cell |
| 16 | chr7:102615200-102615600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
| 17 | chr7:102615600-102618600 | Weak transcription | HUVEC | blood vessel |
| 18 | chr7:102615600-102619000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
| 19 | chr7:102615800-102616600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
| 20 | chr7:102616600-102617000 | Active TSS | Primary neutrophils fromperipheralblood | blood |
| 21 | chr7:102616800-102617600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
| 22 | chr7:102617000-102618000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |






